Amelioration of 1, 2 Dimethylhydrazine Induced Tumor Promotion Response by Novel Benzimidazole Derivative Nanoparticle in Wistar Rats
S.S. Rajendran1★, G. Geetha2, R. Venkatanarayanan1, N. Santhi1★ Corresponding author
- 1Department of Pharmaceutical Chemistry, RVS College of Pharmaceutical Sciences, Sulur, Coimbatore, Tamil Nadu - 641 402, INDIA.
- 2Department of Pharmaceutical Chemistry, PPG College of Pharmacy, Saravanampatti, Coimbatore, Tamilnadu-641 035, INDIA.
CORRESPONDENCE
S.S. Rajendran
Department of Pharmaceutical Chemistry, RVS College of Pharmaceutical Sciences, Sulur, Coimbatore, Tamil Nadu - 641 402, INDIA.
Received: 05-03-2018; Revised: 09-04-2018; Accepted: 04-05-2018.
Volume 10, Issue 3 · pp. 292–298 · PUBLISHED · DOI: 10.5530/jyp.2018.10.65
ABSTRACT
Background:Colon cancer is one of the most common malignancies in many regions of the world and is thought to arise from the accumulation of mutations in a single epithelial cell of the colon and rectum. The benzimidazole comprises a important pharmacophore and privileged structure in modern drug discovery. Various substituted benzimidazole derivatives have been found to possess potential anticancer properties. Objective: The study aimed to prove the anti-colon cancer activity of novel benzimidazole derivative 4-(1H-benzo[d]imidazol-2-yl)-6-phenylpyrimidin-2-amine loaded chitosan nanoparticle (BZI 3 nano) by an 1, 2 Dimethylhydrazine (DMH) Induced rat modelin-vivostudy and identify the targeting efficiency of BZI 3 nano to treat colorectal cancer. Method: The effect of novel benzimidazole derivative 4-(1H-benzo[d]imidazol-2-yl)-6-phenylpyrimidin-2-amine loaded chitosan nanoparticle (BZI 3 nano) on the formation of aberrant crypt foci (ACF), apoptosis, histopathology, body weight, organs weight and heamotological parameters were studied in 1,2-dimethylhydrazine (DMH)-induced colon cancer in rats. Results: BZI 3 nano (5 mg/kg, p.o) administration significantly reduced ACF number and increased the weight gain and apoptotic index compared to DMH treated group. The histological alterations induced by DMH were also significantly improved. Conclusion:In-vivo anticancer activities results revealed that the presence substituted benzimidazole derivative nanoparticle (BZI 3 nano) could have the anticancer potential of the scaffold and selective, good target for drug discovery, which can be regarded as promising anticancer potential.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Rajendran, S., Geetha, G., Venkatanarayanan, R., & Santhi, N. (). Amelioration of 1, 2 Dimethylhydrazine Induced Tumor Promotion Response by Novel Benzimidazole Derivative Nanoparticle in Wistar Rats. Journal of Young Pharmacists, 10(3), 292–298. https://doi.org/10.5530/jyp.2018.10.65
